Physician profile
Bryan A Fox
NPI 1437162815
$56,535.94
in general payments reported to CMS, 2019-2025
14 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $5,304 · 2021: $1,886 · 2022: $8,668 · 2023: $9,772 · 2024: $18K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Royalty Or License: $1,778 · Food and Beverage: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,877.00 |
| Royalty Or License | $1,777.55 |
| Food and Beverage | $690.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Life Spine, INC. | $55,248.19 | 2019-2025 | Arx, Arx, Modular Fixation System |
| Electronic Waveform Lab, INC. | $348.11 | 2021-2023 | |
| Globus Medical, INC. | $183.20 | 2019 | |
| Smith+Nephew, INC. | $169.24 | 2025 | Bone Anchors With Arthroscopic Delivery System, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Biocomposites INC | $135.56 | 2025 | Stimulan |
| Boston Scientific Corporation | $114.11 | 2019-2023 | |
| Cerapedics INC. | $98.99 | 2022 | |
| Depuy Synthes Sales INC. | $93.32 | 2024 | Tfn-Advance, Na |
| Trice Medical, INC. | $29.65 | 2022 | |
| Bioventus LLC | $29.62 | 2019 | |
| Axogen | $26.12 | 2025 | |
| Avanos Medical | $24.04 | 2022 | |
| Sanofi Pasteur INC. | $19.56 | 2025 | |
| Nevro Corp. | $16.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.